The progress of TWEAK and its receptor Fn14 signal pathway in lung diseases
10.3760/cma.j.issn.1008-1372.2018.04.050
- VernacularTitle:TWEAK及其受体Fn14信号通路与肺部疾病的研究进展
- Author:
Xinxin GUAN
1
;
Jianhua ZHANG
;
Xiaoyong LEI
Author Information
1. 南华大学药学与生物科学学院
- Keywords:
TNF-related apoptosis-inducing ligand;
Receptors,TNF-related apoptosis-inducing ligand;
Review
- From:
Journal of Chinese Physician
2018;20(4):635-638
- CountryChina
- Language:Chinese
-
Abstract:
Tumor necrosis factor-like attenuated apoptosis inducer (TWEAK) is a new member of the tumor necrosis factor super family.TWEAK regulates cellular proliferation,differentiation,migration,apoptosis and inflammation by binding its receptor,fibroblast growth factor-inducible 14 (Fn14),through the interaction between cells or in a paracrine fashion.The role of TWEAK / Fn14 signaling pathway in the development of lung diseases such as lung injury,asthma and lung cancer has drawn increasing attention.